Roxadustat for anemia in diabetes-related kidney disease
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a pill called roxadustat can help improve kidney oxygen levels in people with diabetes-related kidney disease and anemia. It may help boost your red blood cells and improve how your kidneys work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes and kidney disease that is causing anemia (low red blood cells).
- You are between 18 and 75 years old.
- You have had diabetes for at least 10 years.
- Your kidney function is moderate to severely reduced (stage 3 or 4).
- Your hemoglobin (oxygen-carrying protein in red blood cells) is below 10 g/dL.
- You are not currently being treated for anemia with erythropoietin drugs, and you are not on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a drug called roxadustat helps people who have heart failure, anemia, and moderate-to-severe chronic kidney disease. The trial focuses on people who have already been taking roxadustat for more than a year.
This study tests whether roxadustat can help improve heart health, nutrition, and reduce inflammation in people on hemodialysis. It may offer a new treatment option for anemia related to kidney disease.
This study tests whether roxadustat, a medicine for anemia, can also help with bone problems and mood or thinking issues in people on hemodialysis.
This trial tests whether a drug called roxadustat (taken as a pill) can help people on dialysis who also have sarcopenia (loss of muscle strength and mass). It aims to see if the drug improves muscle health and anemia.
This trial tests a pill called roxadustat to help treat anemia in people with myelodysplastic syndromes (MDS). It might reduce the need for blood transfusions and improve energy levels.
This study tests a new once-monthly injection called pegmolesatide for anemia in people with kidney disease on dialysis who are already taking roxadustat. It aims to see if switching to this injection can keep hemoglobin levels stable and reduce the need for transfusions.
Hear when a new Diabetes Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.